The TB epidemic from 1992 to 2002

Tuberculosis

Volumn 83, Issue 1-3, 2003, Pages 4-14

  Raviglione, Mario C ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

AFRICA; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DEATH; DEVELOPING COUNTRY; DISEASE CONTROL; EPIDEMIC; FINANCIAL MANAGEMENT; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HEALTH PROMOTION; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MULTIDRUG RESISTANCE; POVERTY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; TREATMENT OUTCOME; TUBERCULOSIS; UNITED STATES; USSR; WORLD HEALTH ORGANIZATION;

EID: 0038182191     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-9792(02)00071-9     Document Type: Conference Paper

References (42)

1. Raviglione MC, Pio A. Evolution of WHO policies for tuberculosis control, 1948-2001. Lancet 2002;359:775-80.
2. Rouillon A. The mutual assistance programme of the IUATLD. Development, contribution and significance. Bull Int Union Tuberc Lung Dis 1991;66:159-72.
3. Enarson DA. The International Union Against Tuberculosis and Lung Disease model national tuberculosis programme. Tuberc Lung Dis 1995;76:95-9.
4. Centers for Disease Control. Tuberculosis - United States, First 39 weeks, 1985. MMWR 1985;34:625-627.
5. Reichman LB. The U-shaped curve of concern. Am Rev Respir Dis 1991;144:741-2.
6. Rieder HL, Cauthen GM, Comstock GW, Snider Jr DE. Epidemiology of tuberculosis in the United States. Epidemiol Rev 1989;11:79-98.
7. Mc Kenna MT, McCray E, Onorato I. The epidemiology of tuberculosis among foreign-born persons in the United States, 1986-1993. N Engl J Med 1995;332:1071-6.
8. Centers for Disease Control Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida, New York, 1988-1991. MMWR 1991;40:585-91.
9. Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991;144:745-9.
10. Frieden TR, Sterling T, Pablos-Mendez A, et al. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993;328:521-6.
11. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City - turning the tide. N Engl J Med 1995;333:229-33.
12. Raviglione MC, Sudre P, Rieder HL, Spinaci S, Kochi A. Secular trends of tuberculosis in Western Europe. Bull World Health Organ 1993;71:297-306.
13. Murray CJL, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990;65:6-24.
14. Sudre P, ten Dam G, Kochi A. Tuberculosis: a global overview of the situation today. Bull World Health Organ 1992;70:149-59.
15. Stanford JL, Grange JM, Pozniak A. Is Africa lost? Lancet 1991;338:557-8.
16. Kochi A. The global tuberculosis situation and the new control stratesy of the World Health Organization. Tubercle 1991;72:1-6.
17. WHO Expert Committee on Tuberculosis. Ninth Report. Technical Reports Series No. 552. Geneva, Switzerland: World Health Organization, 1974.
18. Styblo K. Epidemiological assessment of the current global tuberculosis situation with an emphasis on control in developing countries. Rev Infect Dis 1989;11(Suppl 2): S339-46.
19. World Health Organization. Forty-fourth World Health Assembly. Resolutions and decisions. Resolution WHA 44.8. WHA44/1991/REC/1. Geneva, Switzerland, 1991.
20. World Health Organization. Global Tuberculosis Control. Surveillance, Planning, Financing. WHO Report 2002; Document WHO/CDS/TB/2002.295. Geneva, Switzerland: World Health Organization, 2002.
21. World Bank. World Development Report 1993. Investing in Health. New York, USA: Oxford University Press, 1993 (box 63, p. 63).
22. Murray CJL, De Jonshe E, Chum HJ, et al. Cost-effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries. Lancet 1991;338:1305-8.
23. World Health Organization Global Tuberculosis Programme. Framework for effective tuberculosis control. Document WHO/TB/94.179. Geneva, Switzerland: World Health Organization, 1994.
24. Klaudt K. The political causes, solutions of the current tuberculosis epidemic. In: Whitman J, editor. The politics of emerging and resurgent infectious diseases. Basingstoke: Macmillan Press, 2000. p. 223 ISBN 0.333.69127.X.
25. China Tuberculosis Control Collaboration. Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. Lancet 1996;347:358-62.
26. Raviglione MC, Dye C, Schmidt S, Kochi A. Assessment of worldwide tuberculosis control. Lancet 1997;350:624-9.
27. World Health Organization. Global Tuberculosis Programme. Report of the ad-hoc Committee on the Tuberculosis Epidemic. Document WHO/TB/98.245. London 17-19 March 1998. Geneva, Switzerland: World Health Organization, 1998.
28. World Health Organization Strategic framework to decrease the burden of TB/HIV. Document WHO/CDS/TB/2002.296, WHO/HIV_AIDS/2002.2 Geneva, Switzerland: World Health Organization, 2002.
29. Pablos-Mendez A, Raviglione MC, Laszlo A, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. N Engl J Med 1998;338:1641-9.
30. Espinal MA, Laszlo A, Simonsen L, et al. Global trends in resistance to anti-tuberculosis drugs. N Engl J Med 2001;344:1294-303.
31. Espinal MA, Dye C, Raviglione M, Kochi A. Rational "DOTS Plus" for the control of MDR-TB. Int J Tuberc Lung Dis 1999;3:561-3.
32. Suarez PG, Floyd K, Portocarrero J, et al. Feasibility and cost-effectiveness of standardized second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru. Lancet 2002;359:1980-9.
33. Stop TB Initiative. Tuberculosis and sustainable development. Amsterdam 22-24 March 2000. Report of a Conference. Document WHO/CDS/STB/2000.6. Geneva, Switzerland: World Hearth Organization, 2000.
34. Global DOTS Expansion Plan - Progress in TB control in high-burden countries 2001, 1 year after the Amsterdam Ministerial Conference. Document WHO/CDS/STB/2001.11. Geneva, Switzerland: World Health Organization, 2001.
35. Floyd K, Blanc L, Raviglione MC, Lee JW. Resources required for global tuberculosis control. Science 2002;295:2040-1.
36. Stop TB Partnership. The global plan to stop tuberculosis. Document WHO/CDS/STB/2001.16. Geneva, Switzerland: World Health Organization, 2002.
37. Corbett EL, Watt CJ, Walker N et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med (in press).
38. Maher D, Gorkom JLC van, Gondrie PCFM, Raviglione M. Community contribution to tuberculosis care in high tuberculosis prevalence countries: past, present and future. Int J Tuberc Lung Dis 1999;3:762-8.
39. Chaulet P. After health sector reform, whither lung health? Int J Tuberc Lung Dis 1998;2:349-59.
40. Uplekar M, Pathania V, Raviglione M. Private practitioners and public health: weak links in tuberculosis control. Lancet 2001;358:912-6.
41. Dye C, Fenszeng Z, Scheele S, Williams B. Evaluating the impact of tuberculosis control: number of deaths prevented by short-course chemotherapy in China. Int J Epidemiol 2000;29:558-64.
42. Suarez PG, Watt CJ, Alarćon, et al. The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru. J Infect Dis 2001;184:473-8.